Novel derivatives of monascus pigment having a high CETP inhibitory activity.

about

De Novo RNA Sequencing and Transcriptome Analysis of Monascus purpureus and Analysis of Key Genes Involved in Monacolin K Biosynthesis Beneficial Effects of Monascus sp. KCCM 10093 Pigments and Derivatives: A Mini Review.

P2860

Q28818530-C77CF93C-185E-4C26-9C8F-194E6BB27106 Q47200257-BC262746-A100-43F8-BDC3-BB388210B982

P2860

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

Item

http://www.wikidata.org/entity/Q46907882

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

@en

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

@nl

type

Item

label

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

@en

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

@nl

prefLabel

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

@en

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

@nl

P1476

Novel derivatives of monascus pigment having a high CETP inhibitory activity

@en

P2093

Chul Soo Shin

http://www.w3.org/2001/XMLSchema#string

Heeyoung Jang

http://www.w3.org/2001/XMLSchema#string

P2860

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease.

Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.

Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.

Future of cholesteryl ester transfer protein inhibitors.

Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors.

Biochemical characterization of cholesteryl ester transfer protein inhibitors

Apple polyphenols inhibit plasma CETP activity and reduce the ratio of non-HDL to HDL cholesterol.

P304

1427-1431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14786419.2014.905561

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Deokyeong Choe

P577

2014-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24716720

http://www.w3.org/2001/XMLSchema#string

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

about

P2860

P2860

Novel derivatives of monascus pigment having a high CETP inhibitory activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698